tirzepatide in india Eli Lilly launches weight-loss drug Mounjaro India, beats Novo Nordisk to major market India to finally approve weight

Key Background Doctors have increasingly prescribed injectable diabetes drugs like Ozempic for off-labelor unapprovedweight loss uses

People who experience weight stigma may cope by engaging in unhealthy behaviors, such as: Increasing alcohol and substance use Overeating to deal with negative emotions Avoiding healthcare settings or social encounters The negative health outcomes resulting from weight discrimination can be severe, with studies finding a 60% increased risk of death, even when controlling for body mass index (BMI)

Amylin Receptor Agonism Research Cagrilintide actively engages amylin receptors in research models

The role of endogenous GIP and GLP-1 in postprandial bone homeostasis

1,2 It is likely that this will also be a class effect for all long-acting GLP-1RAs

At this stage, this emerging data should be seen as being hypothesis-generating, rather than practice-changing